Last reviewed · How we verify

NCT05444777

The Effect of Low Dose Ketamine on Narcotic Consumption in Patients Undergoing Laparoscopic Cholecystectomy

Completed NA Last updated 11 July 2023
What this trial tests

NA trial testing Ketamine Hydrochloride in Cholelithiasis in 86 participants. Completed in 30 November 2013.

Timeline
17 January 2013
Primary endpoint
30 November 2013
30 November 2013

Quick facts

Lead sponsorAga Khan University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment86
Start date17 January 2013
Primary completion30 November 2013
Estimated completion30 November 2013

Drugs / interventions tested

Conditions studied

Sponsor

Aga Khan University

Who can join

Adults 18 to 65, any sex, with Cholelithiasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This double-blinded randomized control trial aims to analyze the effect of low dose Ketamine on narcotic consumption, in patients undergoing Laparoscopic cholecystectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ketamine Hydrochloride

Trials testing the same drug.

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

Other Aga Khan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05444777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing